Jaime A H Mullin

Jaime Mullin practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Jaime Mullin's NPI, 1801092093, was assigned on June 25, 2007. Jaime Mullin holds Pennsylvania license OS014591.

Jaime Mullin's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Jaime Mullin's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Jaime Mullin is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is UPMC Hillman Cancer Center. Dmand AI also links Jaime Mullin to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jaime Mullin practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Jaime Mullin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Jaime Mullin is licensed in Pennsylvania.

CMS data shows 1,054 Medicare services from Jaime Mullin across 4 procedure codes in 2024, for 282 Medicare patients. Medicare paid $88,864 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 282 Medicare patients who saw Jaime Mullin in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jaime Mullin's median patient age at 72, with 44% women.

In 2024, Jaime Mullin wrote 22 Medicare Part D claims for 16 patients. 82% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $208 in total drug cost. In 2022, CMS named 43 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Jaime Mullin for performance year 2024, reported as part of a group. Jaime Mullin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Jaime Mullin from 5 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $241.